Other checkpoint proteins of importance in glioma biology include the immunomodulator B7-H3 (CD276) and the tryptophan-degrading enzyme indoleamine-2,3-dioxygenase (IDO1). This evidence concerns the gene PROS1 and central nervous system cancer.